Funding for this research was provided by:
Tehran University of Medical Sciences and Health Services (1392-02-107-1713)
Received: 14 March 2022
Accepted: 7 June 2022
First Online: 21 June 2022
: This study was approved by the Ethics Committee of Endocrinology and Metabolism Research Institute, Tehran University of Medical Sciences, Tehran, Iran (IRB code: EC-00264). All studies were carried out in compliance with the ARRIVE guidelines (https:// arriveguidelines. org) for the reporting of animal experiments. All methods were performed in accordance with the relevant guidelines and regulations.
: Not applicable.
: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.